Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What is the place of POEMS syndrome in the current classification of monoclonal gammopathies of renal significance?

Literature DB >> 29134615

What is the place of POEMS syndrome in the current classification of monoclonal gammopathies of renal significance?

Mariana Ciocchini¹, Carlos Guido Musso².

Abstract

Entities: Disease

Mesh：

Year: 2017 PMID： 29134615 DOI： 10.1007/s11255-017-1739-z

Source DB: PubMed Journal: Int Urol Nephrol ISSN： 0301-1623 Impact factor: 2.370

× No keyword cloud information.

11 in total

Review 1. Dangerous small B-cell clones.

Authors: Giampaolo Merlini; Marvin J Stone
Journal: Blood Date: 2006-06-22 Impact factor: 22.113

Review 2. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.

Authors: Mariana Ciocchini; Jorge Arbelbide; Carlos G Musso
Journal: Int Urol Nephrol Date: 2017-04-19 Impact factor: 2.370

3. Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome.

Authors: Wei Ye; Chen Wang; Qian-Qian Cai; Hao Cai; Ming-Hui Duan; Hang Li; Xin-Xin Cao; Dao-Bin Zhou; Jian Li
Journal: Nephrol Dial Transplant Date: 2015-06-30 Impact factor: 5.992

4. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome.

Authors: Y Nakamoto; H Imai; T Yasuda; H Wakui; A B Miura
Journal: Nephrol Dial Transplant Date: 1999-10 Impact factor: 5.992

5. Thrombotic microangiopathy associated with monoclonal gammopathy.

Authors: Aishwarya Ravindran; Ronald S Go; Fernando C Fervenza; Sanjeev Sethi
Journal: Kidney Int Date: 2016-12-18 Impact factor: 10.612

Review 6. Diagnosis of monoclonal gammopathy of renal significance.

Authors: Frank Bridoux; Nelson Leung; Colin A Hutchison; Guy Touchard; Sanjeev Sethi; Jean-Paul Fermand; Maria M Picken; Guillermo A Herrera; Efstathios Kastritis; Giampaolo Merlini; Murielle Roussel; Fernando C Fervenza; Angela Dispenzieri; Robert A Kyle; Samih H Nasr
Journal: Kidney Int Date: 2015-01-21 Impact factor: 10.612

1. Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?

Authors: Mariana Ciocchini; Carlos G Musso
Journal: Int Urol Nephrol Date: 2018-05-28 Impact factor: 2.370

1 in total

What is the place of POEMS syndrome in the current classification of monoclonal gammopathies of renal significance?

Review 1. Dangerous small B-cell clones.

Review 2. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.

3. Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome.

4. A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome.

5. Thrombotic microangiopathy associated with monoclonal gammopathy.

Review 6. Diagnosis of monoclonal gammopathy of renal significance.

7. Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.

8. [Renal manifestation in POEMS syndrome].

Review 9. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management.

10. Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits.

1. Which should be the correct treatment for monoclonal gammopathy of renal significance with complement alternative pathway dysregulation (C3 glomerulopathy and atypical hemolytic uremic syndrome): clone-directed or anticomplement therapy?